Definitive Healthcare (NASDAQ:DH) Trading Up 6.8% – Time to Buy?

Definitive Healthcare Corp. (NASDAQ:DH) shares traded up 6.8% during mid-day trading on Tuesday . The company traded as high as $4.91 and last traded at $4.94. 899,586 shares traded hands during mid-day trading, an increase of 15% from the average session volume of 781,061 shares. The stock had previously closed at $4.62.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on DH. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Stephens assumed coverage on Definitive Healthcare in a research report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective for the company. Finally, Barclays restated an “underweight” rating and set a $4.00 target price on shares of Definitive Healthcare in a report on Monday, January 13th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Definitive Healthcare presently has an average rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Stock Performance

The stock’s 50 day moving average is $4.41 and its two-hundred day moving average is $4.45. The stock has a market capitalization of $568.36 million, a price-to-earnings ratio of -1.59, a price-to-earnings-growth ratio of 3.54 and a beta of 1.41. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH) last released its earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.03). The firm had revenue of $62.70 million during the quarter, compared to the consensus estimate of $61.66 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. During the same quarter in the previous year, the firm posted $0.01 EPS. Analysts expect that Definitive Healthcare Corp. will post 0.15 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This represents a 9.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 14.84% of the company’s stock.

Hedge Funds Weigh In On Definitive Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. Massachusetts Financial Services Co. MA lifted its holdings in Definitive Healthcare by 36.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after purchasing an additional 1,626,813 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of Definitive Healthcare during the second quarter worth $9,283,000. State Street Corp boosted its position in shares of Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after acquiring an additional 317,952 shares during the period. 272 Capital LP grew its stake in shares of Definitive Healthcare by 74.8% in the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock valued at $4,980,000 after acquiring an additional 476,766 shares in the last quarter. Finally, Victory Capital Management Inc. increased its position in Definitive Healthcare by 6.5% during the third quarter. Victory Capital Management Inc. now owns 542,170 shares of the company’s stock worth $2,424,000 after acquiring an additional 33,161 shares during the period. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.